Dealing in securities by executive directors, prescribed officers and company secretary
Johannesburg, 30 November 2023. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:
In line with the provisions of the 2018 Harmony Deferred Share Plan, executive directors and prescribed officers of Harmony were awarded deferred shares on 18 September 2023 based on the 5-day volume weighted average price of R83.09 per ordinary share and accepted these awards on 29 November 2023. In addition, in compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, dealing in securities by a prescribed officer is disclosed.
The following transactions are disclosed in relation to the deferred share awards:
| 1. | Name of director: | PW Steenkamp (Chief Executive Officer) |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 107 359 | |
| Total value of shares awarded: | R8 920 459.31 | |
| Nature and extent of director’s interest: | Direct beneficial | |
| 2. | Name of director: | B Lekubo (Financial Director) |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 59 022 | |
| Total value of shares awarded: | R4 904 137.98 | |
| Nature and extent of director’s interest: | Direct beneficial | |
| 3. | Name of director: | HE Mashego (Executive Director) |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 52 657 | |
| Total value of shares awarded: | R4 375 270.13 | |
| Nature and extent of director’s interest: | Direct beneficial | |
| 4. | Name of prescribed officer: | AZ Buthelezi |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 49 559 | |
| Total value of shares awarded: | R4 117 857.31 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 5. | Name of prescribed officer: | BB Nel |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 66 512 | |
| Total value of shares awarded: | R5 526 482.08 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial |
| 6. | Name of prescribed officer: | MP van der Walt |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 49 559 | |
| Total value of shares awarded: | R4 117 857.31 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| Date of transaction | 30 November 2023 | |
| Type of transaction: | On-market sale of ordinary shares | |
| Class of securities: | Ordinary shares | |
| Number of shares: | 49 000 | |
| Volume Weighted Average price per share: | R116.5766 | |
| Highest sale price: | R117.65 | |
| Lowest sale price: | R116.25 | |
| Total value of shares: | R5 712 253 | |
| Nature and extent of interest | Direct beneficial | |
| 7. | Name of prescribed officer: | JJ van Heerden |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in five equal tranches over a five year period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 66 151 | |
| Total value of shares awarded: | R5 496 486.59 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 8. | Name of company secretary: | SS Mohatla |
| Nature of transaction: | Off market award of deferred shares | |
| Periods of vesting: | Deferred shares vest in three equal tranches over a three period | |
| Class of securities: | Deferred ordinary shares | |
| Number of deferred shares awarded: | 19 737 | |
| Total value of shares awarded: | R1 639 947.33 | |
| Nature and extent of company secretary’s interest: | Direct beneficial |
Prior clearance was obtained in respect of the above dealings by the executive directors, prescribed officers and company secretary.
Ends.
For more details contact:
Jared Coetzer
Head of Investor Relations
+27 (0) 82 746 4120
Johannesburg, South Africa
30 November 2023
Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited